IDXX vs MD · P/E 40, rev $2.36B vs P/E 11, rev $964.0M
IDEXX Laboratories Inc (IDXX) versus Mednax Inc (MD) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Mednax Inc (MD) is a medical care facilities company listed on NYSE.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported MD revenue for 2026-06-30 was $964.0M. Net income was $69.4M. MD currently screens at market cap $1.93B and trailing P/E 11.4.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. MD currently screens at market cap $1.93B and trailing P/E 11.4.
Not investment advice. Open the IDXX and MD stock pages for the full models.
Not investment advice.